TRADING_as_a_BUSINESS

ATNM Technical Analysis 🧙

āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™
TRADING_as_a_BUSINESS āļ—āļĩāđˆāļ­āļąāļ›āđ€āļ”āļ•:   
AMEX:ATNM   Actinium Pharmaceuticals, Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

If you understand the idea,ðŸŽŊ press a thumb up! 👍 Have a question? Don't be shy to ask! ðŸĪ“ Interested to study how to analyze charts, follow me!
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļĒāļąāļ‡āļ„āļ‡āļ”āļģāđ€āļ™āļīāļ™āļ­āļĒāļđāđˆ:
got 1st take profit
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļĒāļąāļ‡āļ„āļ‡āļ”āļģāđ€āļ™āļīāļ™āļ­āļĒāļđāđˆ:
got 2nd take profit

āļ„āļģāļˆāļģāļāļąāļ”āļŠāļīāļ—āļ˜āļīāđŒāļ„āļ§āļēāļĄāļĢāļąāļšāļœāļīāļ”āļŠāļ­āļš

āļ‚āđ‰āļ­āļĄāļđāļĨāđāļĨāļ°āļšāļ—āļ„āļ§āļēāļĄāđ„āļĄāđˆāđ„āļ”āđ‰āļĄāļĩāļ§āļąāļ•āļ–āļļāļ›āļĢāļ°āļŠāļ‡āļ„āđŒāđ€āļžāļ·āđˆāļ­āļāđˆāļ­āđƒāļŦāđ‰āđ€āļāļīāļ”āļāļīāļˆāļāļĢāļĢāļĄāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™, āļāļēāļĢāļĨāļ‡āļ—āļļāļ™, āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ, āļ‚āđ‰āļ­āđ€āļŠāļ™āļ­āđāļ™āļ° āļŦāļĢāļ·āļ­āļ„āļģāđāļ™āļ°āļ™āļģāļ›āļĢāļ°āđ€āļ āļ—āļ­āļ·āđˆāļ™ āđ† āļ—āļĩāđˆāđƒāļŦāđ‰āļŦāļĢāļ·āļ­āļĢāļąāļšāļĢāļ­āļ‡āđ‚āļ”āļĒ TradingView āļ­āđˆāļēāļ™āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ—āļĩāđˆ āđ€āļ‡āļ·āđˆāļ­āļ™āđ„āļ‚āļāļēāļĢāđƒāļŠāđ‰āļšāļĢāļīāļāļēāļĢ